文献速递鼻科

适应性鼻窦结局测试(SNOT)的验证研究

Validation of an Adaptive Sinonasal Outcome Test.
PubMed 文献 · JAMA Otolaryngol Head Neck Surg · 2026-01-01

本研究评估适应性SNOT能否作为验证工具,纳入1072例15岁以上连续患者,对其中70例进行鼻窦CT检查。结果显示适应性SNOT的鼻域和全域评分能区分Lund-Mackay CT评分≥5与<5的患者,且与整体健康相关,重测信度良好,并对药物或手术治疗有反应性。结论支持该工具用于评估慢性鼻窦炎和过敏性鼻炎相关症状。

要点

  • 适应性SNOT鼻域评分可区分CT评分≥5与<5的患者(Cohen d=0.80)。
  • 重测信度良好,鼻域Cohen κ为0.72-0.74,全域为0.73-0.75。
  • 治疗后评分从均值9.12降至2.47,显示对变化有反应性。

核心结论

  • 适应性SNOT工具可用于临床和研究中评估慢性鼻窦炎及过敏性鼻炎相关症状。

研究设计与样本

  • 验证性诊断研究,纳入1072例15岁及以上连续患者,其中70例完成鼻窦CT检查。
  • 数据收集于2024年1月至2025年8月,分析于2025年8月至9月。

主要发现

  • 鼻域评分区分Lund-Mackay CT评分≥5与<5的均数差为0.33(95%CI 0.03-0.63),Cohen d=0.80。
  • 全域评分区分上述两组的均数差为3.04(95%CI 0.02-6.05),Cohen d=0.57。
  • 适应性SNOT评分与躯体、心理、社会和整体健康存在关联(关联程度从低到强)。
  • 鼻域重测信度Cohen κ为0.72-0.74,全域为0.73-0.75。
  • 接受药物或手术治疗的慢性鼻窦炎患者评分从均值9.12(95%CI 6.37-11.87)改善至2.47(95%CI 0.89-4.05),Cohen d=0.76。

关键数值与推荐

  • Lund-Mackay CT评分≥5与<5用于分组比较适应性SNOT评分的区分效度。
  • 采用Spearman ρ评估聚合效度,Cohen κ、Spearman ρ和组内相关系数评估重测信度。

临床怎么用

  • 可将适应性SNOT用于慢性鼻窦炎和过敏性鼻炎患者的症状评估及治疗效果随访。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: The Sino-Nasal Outcome Test (SNOT) is used worldwide to assess chronic rhinosinusitis (CRS). An adaptive form of this instrument has established concordance between subjective patient-reported outcomes and objective imaging findings, but its broader psychometric properties have yet to be evaluated. OBJECTIVE: To evaluate whether the adaptive SNOT can function as a validated instrument. DESIGN, SETTING, AND PARTICIPANTS: This validation diagnostic study of internal consistency, reliability, responsiveness, and convergent and discriminant validity of an adaptive SNOT instrument included consecutive patients 15 years and older who prospectively completed the adaptive SNOT, including factor analysis on 1072 responses. Computed tomography (CT) imaging of the sinuses was performed in 70 patients. Data were collected from January 2024 to August 2025, and data were analyzed from August to September 2025. EXPOSURES: CRS and allergy-related symptoms as well as secondary ear, sleep, psychological, and productivity domains were assessed through completion of the adaptive SNOT instrument. Lund-Mackay CT scores (LMCT) were calculated to measure objective disease severity in sinus imaging, while Patient-Reported Outcomes Measurement Information System scores were used to assess general health. MAIN OUTCOMES AND MEASURES: Factor analysis and internal consistency were assessed. Adaptive SNOT scores in patients with LMCT scores less than 5 or 5 and greater were evaluated via differences in means and effect sizes. Convergent validity was evaluated with Spearman ρ. Intrarater reliability was evaluated with Cohen κ, Spearman ρ, and intraclass correlation coefficient. RESULTS: Of 1072 included patients, 782 (72.9%) were female, and the mean (SD) age was 54 (21) years. The adaptive SNOT nasal domain and all-domain scores clearly distinguished between patients with LMCT scores of 5 and greater and those with LMCT scores less than 5 (nasal domain score: difference in means, 0.33; 95% CI, 0.03-0.63; Cohen d = 0.80; all-domain score: difference in means, 3.04; 95% CI, 0.02-6.05; Cohen d = 0.57). Adaptive SNOT scores also demonstrated associations with physical, mental, social, and global health (associations ranged from low to strong). Intrarater reliability was substantial for both the nasal domain alone (Cohen κ range, 0.72-0.74) and across all domains (Cohen κ range, 0.73-0.75). Additionally, the adaptive SNOT nasal and all-domain scores were responsive to change and improved among patients who received CRS treatment with medication or surgery from a mean score of 9.12 (95% CI, 6.37-11.87) to 2.47 (95% CI, 0.89-4.05) (Cohen d = 0.76). CONCLUSIONS AND RELEVANCE: Findings of this validation diagnostic study support the validation of the adaptive SNOT instrument for assessing CRS-related and allergic rhinitis-related symptoms in clinical and research settings.

来源:JAMA Otolaryngol Head Neck Surg,查看原文。版权归原作者所有。

引用

  1. Zhang SK, Gilani S, Stanlie A, et al. Validation of an Adaptive Sinonasal Outcome Test. JAMA Otolaryngol Head Neck Surg. 2026. PMID: 42133337. doi:10.1001/jamaoto.2026.1008

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。